Desymmetrization of meso-Bicyclic Hydrazines
reactions were performed under an atmosphere of nitrogen. THF
was dried with CaCl2, filtered through basic alumina, and distilled
from Na under an atmosphere of nitrogen. Toluene was distilled
from Na under an atmosphere of nitrogen. Substrates S1–S3 were
prepared following reported procedures.[15]
220 nm, flow = 0.8 mLmin–1; eluent = hexane/iPrOH, 70:30): tR1
= 11.9 min, tR2 = 13.8 min.
2-(Hydroxymethyl)-1,4-methano-1,2,3,4-tetrahydropyridazino-
[1,2-b]phthalazine-6,11-dione (P3): Yellow oil (125 mg, 42%). 1H
NMR (400 MHz, CDCl3): δ = 1.66 (m, 1 H), 2.08 (s, 2 H), 2.15
(m, 1 H), 2.45 (m, 1 H), 3.53 (m, 1 H), 3.69 (br. s, 1 H), 3.75 (m,
1 H), 5.37 (br. s, 1 H), 5.43 (br. s, 1 H), 7.76 (m, 2 H), 8.26 (m, 2
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 31.8, 35.4, 43.7, 58.6,
60.4, 63.9, 127.3, 129.9, 133.1, 153.4, 153.7 ppm. MS (ES): m/z =
281 [M + Na]+. HPLC (concentration = 0.1 gL–1 in a 20-mL injec-
tion loop; Chiralpack AD column, 0.46 cm I.D. ϫ 25 cm, equipped
with a precolumn, 0.46 cm I. D. ϫ 5 cm; λ = 220 nm; flow =
0.8 mLmin–1; eluent = hexane/iPrOH, 80:20): tR1 = 14.18 min, tR2
= 15.56 min.
General Procedure for Hydroformylation: Under an atmosphere of
nitrogen, a Schlenk flask was charged with a magnetic stir bar,
Rh(acac)(CO)2 (2.6 mg, 0.01 mmol), the chiral auxiliary
(0.02 mmol), and toluene (5 mL). The solution was stirred at room
temperature for 1 h. The substrate (1 mmol) was placed in a
double-walled stainless steel autoclave equipped with a stir bar un-
der an atmosphere of nitrogen. The solution containing the rho-
dium precatalyst was transferred into the autoclave by cannula un-
der an atmosphere of nitrogen. The autoclave was then pressurized
with syngas (CO/H2, 1:1) at the selected pressure and placed at the
desired temperature. At the end of the reaction, the autoclave was
cooled to room temperature and depressurized. Toluene was evapo-
rated under reduced pressure. The crude residue was dissolved in
methanol, and the mixture was cooled to 0 °C. NaBH4 (113 mg,
3 mmol) was added in small portions over 30 min. Then, ethyl ace-
tate (30 mL) and saturated ammonium chloride (10 mL) were
added. The aqueous phase was extracted with ethyl acetate
(2ϫ30 mL). The combined organic layers were washed with brine
(20 mL) and dried with magnesium sulfate. After filtration and
evaporation of the solvent, the crude residue was purified through
silica gel flash chromatography.
Chemical Correlation: [Rh(cod)Cl]2 (5 mg, 0.01 mmol), (S,S)-bdpp
(8.8 mg, 0.02 mmol), and S1 (365 mg, 1 mmol) were placed in a
Schlenk tube, dried under vacuum (0.1 Torr) for 1 h, and then
placed under an atmosphere of argon. DME (4 mL) was degassed
at –50 °C and added to the mixture at this temperature. The yellow-
green slurry was stirred at –50 °C for 30 min. Catecholborane
(210 µL, 2 mmol) was then added dropwise, and the mixture be-
came orange but remained heterogeneous. The reaction was kept
at –50 °C for an additional 30 min. The solvent and the excess
amount of reagent were then carefully removed under vacuum
(0.1 Torr, 3 h) to give intermediate borane 4 as a dark-yellow foam.
A solution of 4 in THF (6 mL) under an atmosphere of argon was
then added over a 2- solution of trimethylsilyldiazomethane in
Et2O (2.5 mL, 5 mmol). After heating at reflux overnight, freshly
prepared mixture of 2 aqueous sodium hydroxide and 30% hy-
drogen peroxide (1:1, 10 mL) were then added dropwise at 0 °C,
which turned the solution to black. The mixture was stirred for an
additional 4 h at room temperature. After extraction with EtOAc
(3ϫ20 mL), the combined organic layers was washed with 1 HCl
(20 mL), dried with MgSO4, filtered, and concentrated. The crude
reaction mixture was then purified by silica gel flash chromatog-
raphy (cyclohexane/ethyl acetate, 2:1) to give 5 as a mixture of dia-
stereomers (446 mg, 95%). Tetrabutylammonium fluoride (250 mg,
0.8 mmol) was added to a solution of 5 (188 mg, 0.4 mmol) in THF
(2 mL) and stirred at room temperature for 24 h. More reagent was
then added (250 mg, 0.8 mmol), and the mixture was kept at room
temperature until complete consumption of the starting material.
After concentration under vacuum, the crude reaction mixture was
purified by silica gel flash chromatography to give 3 (138 mg, 87%).
The absolute configuration of compound 3 was established from
the known configuration of compound 6, obtained by an oxidative
treatment of boronate 5.[7]
Dibenzyl 5-Formyl-2,3-diazabicyclo[2.2.1]heptane-2,3-dicarboxylate
(2): Yellow oil (330 mg, 84%). 1H NMR (400 MHz, CDCl3): δ =
1.46 (d, J = 10.5 Hz, 1 H), 1.69 (d, J = 10.5 Hz, 1 H), 1.81–2.20
(m, 2 H), 2.99 (br. s, 1 H), 4.51–5.15 (m, 2 H), 5.10–5.27 (m, 4 H),
7.26–7.34 (m, 10 H), 9.46 (br. s, 1 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 29.3, 36.2, 52.3, 60.5, 68.3, 128.1, 128.4, 128.7, 135.9,
157.2, 199.1 ppm.
Dibenzyl 5-(Hydroxymethyl)-2,3-diazabicyclo[2.2.1]heptane-2,3-di-
carboxylate (3, P1): Yellow oil (364 mg, 80%). 1H NMR (400 MHz,
CDCl3): δ = 1.00–1.30 (m, 1 H), 1.50–1.70 (m, 2 H), 1.80–2.00 (m,
1 H), 2.10–2.40 (m, 2 H), 3.20–3.40 (m, 1 H), 3.40–3.60 (br. s, 1
H), 4.40–4.80 (m, 2 H), 5.10–5.30 (m, 4 H), 7.26–7.32 (m, 10 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 32.5, 35.3, 42.7, 60.5, 62.1,
64.2, 68.1, 128.1, 128.3, 128.6, 136.1, 157.7 ppm. HRMS: calcd.
for C22H25N2O5 397.1763; found 397.1765. HPLC (concentration
= 0.1 gL–1 in a 20-mL injection loop; Chiralpack AD column,
0.46 cm I.D. ϫ 25 cm, equipped with a precolumn, 0.46 cm I. D.
ϫ 5 cm; λ = 220 nm; flow = 0.8 mLmin–1; eluent = hexane/iPrOH,
70:30): tR1 = 11.87 min, tR2 = 13.81 min.
3,5-Dioxo-4-phenyl-2,4,6-triazatricyclo[5.2.1.02,6]decane-8-carbal-
dehyde: White amorphous solid (270 mg, 99 %). 1H NMR
(300 MHz, CDCl3): δ = 1.70 (d, J = 11.0 Hz, 1 H), 1.91 (d, J =
11.0 Hz, 1 H), 2.15 (dd, J = 11.5, 9.0 Hz, 1 H), 2.29 (m, 1 H), 3.26
(m, 1 H), 4.99 (s, 1 H), 5.31 (s, 1 H), 7.40 (m, 1 H), 7.47 (m, 4 H),
9.78 (s, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 28.7, 36.9,
52.4, 60.1, 125.5, 128.6, 129.4, 131.4, 157.0, 198.2 ppm.
8-(Hydroxymethyl)-4-phenyl-2,4,6-triazatricyclo[5.2.1.02,6]decane-
3,5-dione (P2): White solid (245 mg, 90%). M.p. 180–182 °C. 1H
NMR (300 MHz, CDCl3): δ = 1.47 (ddd, J = 13.0, 5.0, 3.0 Hz, 1
H), 1.94 (m, 2 H), 2.11 (m, 2 H), 2.41 (m, 1 H), 3.44 (m, 1 H), 3.64
(m, 1 H), 4.68 (br. s, 1 H), 4.88 (br. s, 1 H), 7.40 (m, 1 H), 7.47 (m,
2 H), 7.49 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 31.5,
36.2, 43.0, 60.3, 61.9, 63.7, 125.6, 128.5, 129.3, 131.6, 157.0 ppm.
MS (ES): m/z = 296 [M + Na]+. HPLC (concentration: 0.1 gL–1 in
a 20-mL injection loop; Chiralpack AD column. 0.46 cm I.D. ϫ
25 cm, equipped with a precolumn, 0.46 cm I. D. ϫ 5 cm; λ =
Acknowledgments
We thank Pr. Kyoko Nozaki for a generous gift of binaphos. We
thank the “Centre National de la Recherche Scientifique” and the
“Ministère de la Recherche et de l’Enseignement Supérieur” (grant
to C. B.) for financial support.
[1] a) F. Agbossou, J.-F. Carpentier, A. Mortreux, Chem. Rev.
1995, 95, 2485–2506; b) C. Claver, P. W. N. M. van Leeuwen,
Rhodium Catalyzed Hydroformylation; Kluwer Academic Pub-
lishers, Dordrecht, 2000; c) S. Gladiali, J. C. Bayön, C. Claver,
Tetrahedron: Asymmetry 1995, 6, 1453–1474; d) M. Diéguez,
O. Pamies, C. Claver, Tetrahedron: Asymmetry 2004, 15, 2113–
2122; e) B. Breit, W. Seiche, Synthesis 2001, 1–36.
[2] a) J. Klosin, C. L. Landis, Acc. Chem. Res. 2007, 40, 1251–
1259; b) C. Claver, M. Diéguez, O. Pamier, S. Castillón in Top-
Eur. J. Org. Chem. 2008, 2298–2302
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2301